New York Attorney General Eric Schneiderman today applauded the U.S. Supreme Court’s decision that pay-for-delay settlements of drug-patent litigation may be challenged as potential violations of antitrust law.
The ruling is a “victory” for millions of Americans who depend on generic drugs to treat illness and pain, Schneiderman said in the news release.
“As we argued in our brief to the Supreme Court, pay-for-delay drug settlements should receive serious scrutiny because they are frequently anticompetitive, unlawful, and harmful to health-care consumers across the country. This decision makes clear that drug companies can be sued to stop anticompetitive pay-for-delay agreements. It will be an important weapon in the fight for affordable drug prices and quality healthcare for every citizen,” Schneiderman said.
(Sponsored)
Tips, Overtime and More: Are You Ready for the One Big Beautiful Bill?
Since officially becoming law on Independence Day 2025, the One Big Beautiful Bill Act (OBBBA) has led to significant changes in both individual and business taxes. For businesses with employees
Don’t Let Workforce Challenges Daunt You
Finding and retaining top talent to grow your organization can be daunting. Many industries are grappling with unfilled positions, rising turnover costs, and skills gaps. These issues can slow progress
Schneiderman in January led a coalition of 36 states, plus the District of Columbia and the Commonwealth of Puerto Rico, in arguing that the Supreme Court should allow antitrust enforcers to challenge pay-for-delay settlements as anticompetitive and unlawful, according to the news release.
Contact Reinhardt at ereinhardt@cnybj.com
